Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Int J Mol Sci ; 22(17)2021 Sep 04.
Article in English | MEDLINE | ID: mdl-34502509

ABSTRACT

Excess aldosterone promotes pathological remodeling of the heart and imbalance in cardiac ion homeostasis of sodium, potassium and calcium. Novel treatment with proanthocyanidins in aldosterone-treated rats has resulted in downregulation of cardiac SGK1, the main genomic aldosterone-induced intracellular mediator of ion handling. It therefore follows that proanthocyanidins could be modulating cardiac ion homeostasis in aldosterone-treated rats. Male Wistar rats received aldosterone (1 mg kg-1 day-1) +1% NaCl for three weeks. Half of the animals in each group were simultaneously treated with the proanthocyanidins-rich extract (80% w/w) (PRO80, 5 mg kg-1 day-1). PRO80 prevented cardiac hypertrophy and decreased calcium content. Expression of ion channels (ROMK, NHE1, NKA and NCX1) and calcium transient mediators (CAV1.2, pCaMKII and oxCaMKII) were reduced by PRO80 treatment in aldosterone-treated rats. To conclude, our data indicate that PRO80 may offer an alternative treatment to conventional MR-blockade in the prevention of aldosterone-induced cardiac pathology.


Subject(s)
Heart Failure/metabolism , Hypertension/metabolism , Proanthocyanidins/metabolism , Aldosterone/metabolism , Aldosterone/pharmacology , Animals , Cardiomegaly/metabolism , Heart/physiopathology , Heart Failure/drug therapy , Heart Failure/physiopathology , Homeostasis/drug effects , Hypertension/drug therapy , Hypertension/physiopathology , Ion Channels/metabolism , Male , Myocardium/metabolism , Proanthocyanidins/physiology , Rats , Rats, Wistar
2.
Neuromolecular Med ; 20(3): 328-342, 2018 09.
Article in English | MEDLINE | ID: mdl-29846873

ABSTRACT

Docosahexaenoic acid (DHA, 22:6 n-3) is an essential omega-3 (ω-3) long chain polyunsaturated fatty acid of neuronal membranes involved in normal growth, development, and function. DHA has been proposed to reduce deleterious effects in neurodegenerative processes. Even though, some inconsistencies in findings from clinical and pre-clinical studies with DHA could be attributed to the presence of phytanic acid (PhA) in standard DHA treatments. Thus, the aim of our study was to analyze and compare the effects of a low PhA-concentrated DHA with a standard PhA-concentrated DHA under different neurotoxic conditions in BV-2 activated microglial cells. To this end, mouse microglial BV-2 cells were stimulated with either lipopolysaccharide (LPS) or hydrogen peroxide (H2O2) and co-incubated with DHA 50 ppm of PhA (DHA (PhA:50)) or DHA 500 ppm of PhA (DHA (PhA:500)). Cell viability, superoxide anion (O2-) production, Interleukin 6 (L-6), cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), glutathione peroxidase (GtPx), glutathione reductase (GtRd), Caspase-3, and the brain-derived neurotrophic factor (BDNF) protein expression were explored. Low PhA-concentrated DHA protected against LPS or H2O2-induced cell viability reduction in BV-2 activated cells and O2- production reduction compared to DHA (PhA:500). Low PhA-concentrated DHA also decreased COX-2, IL-6, iNOS, GtPx, GtRd, and SOD-1 protein expression when compared to DHA (PhA:500). Furthermore, low PhA-concentrated DHA increased BDNF protein expression in comparison to DHA (PhA:500). The study provides data supporting the beneficial effect of low PhA-concentrated DHA in neurotoxic injury when compared to a standard PhA-concentrated DHA in activated microglia.


Subject(s)
Docosahexaenoic Acids/pharmacology , Microglia/drug effects , Neuroprotection , Neuroprotective Agents/pharmacology , Phytanic Acid/pharmacology , Animals , Antioxidants/metabolism , Brain-Derived Neurotrophic Factor/biosynthesis , CD11b Antigen/biosynthesis , Cell Line , Cell Survival/drug effects , Docosahexaenoic Acids/therapeutic use , Hydrogen Peroxide/pharmacology , Inflammation/drug therapy , Inflammation/metabolism , Lipopolysaccharides/pharmacology , Mice , Microglia/metabolism , Neuroprotective Agents/therapeutic use , Neurotoxicity Syndromes/drug therapy , Osmolar Concentration , Phytanic Acid/therapeutic use , Superoxides/metabolism
3.
J Vis Exp ; (116)2016 10 18.
Article in English | MEDLINE | ID: mdl-27805599

ABSTRACT

There is increasing evidence suggesting the important role of inflammation and, subsequently, macrophages in the development and progression of renal disease. Macrophages are heterogeneous cells that have been implicated in kidney injury. Macrophages may be classified into two different phenotypes: classically activated macrophages (M1 macrophages), that release pro-inflammatory cytokines and promote fibrosis; and alternatively activated macrophages (M2 macrophages) that are associated with immunoregulatory and tissue-remodeling functions. These macrophage phenotypes need to be discriminated and analyzed to determine their contribution to renal injury. However, there are scarce studies reporting consistent phenotypic and functional information about macrophage subtypes in inflammatory renal disease models, especially in rats. This fact may be related to the limited macrophage markers used in rats, contrary to mice. Therefore, novel strategies are necessary to quantify and characterize the renal content of these infiltrating cells in a reliable way. This manuscript details a protocol for kidney digestion and further phenotypic and quantitative analysis of macrophages from rat kidneys by flow cytometry. Briefly, kidneys were incubated with collagenase and total macrophages were identified according to the dual presence of CD45 (leukocytes common antigen) and CD68 (PAN macrophage marker) in live cells.This was followed by surface staining of CD86 (M1 marker) and CD163 (M2 marker). Rat peritoneal macrophages were used as positive control for macrophage marker detection by flow cytometry. Our protocol resulted in low cellular mortality and allowed characterization of different intracellular and surface protein markers, thus limiting the loss of cellular integrity observed in other protocols. Moreover, this procedure allows the use of macrophages for further techniques, including cell sorting and mRNA or protein expression studies, among others.


Subject(s)
Flow Cytometry , Kidney , Macrophages , Phenotype , Animals , Biomarkers , Cytokines , Inflammation , Mice , Rats
4.
J Nutr Biochem ; 37: 13-19, 2016 11.
Article in English | MEDLINE | ID: mdl-27592201

ABSTRACT

Aldosterone plays a central role in the development of cardiac pathological states involving ion transport imbalances, especially sodium transport. We have previously demonstrated a cardioprotective effect of proanthocyanidins in aldosterone-treated rats. Our objective was to investigate for the first time the effect of proanthocyanidins on serum and glucocorticoid-regulated kinase 1 (SGK1), epithelial Na+ channel (γ-ENaC), neuronal precursor cells expressed developmentally down-regulated 4-2 (Nedd4-2) and phosphoNedd4-2 protein expression in the hearts of aldosterone-treated rats. Male Wistar rats received aldosterone (1mg kg-1day-1)+1% NaCl for 3weeks. Half of the animals in each group were simultaneously treated with the proanthocyanidins-rich extract (80% w/w) (PRO80, 5mg kg-1day-1). Hypertension and diastolic dysfunction induced by aldosterone were abolished by treatment with PRO80. Expression of fibrotic, inflammatory and oxidative mediators were increased by aldosterone-salt administration and blunted by PRO80. Antioxidant capacity was improved by PRO80. The up-regulated aldosterone mediator SGK1, ENaC and p-Nedd4-2/total Nedd4-2 ratio were blocked by PRO80. PRO80 blunted aldosterone-mineralocorticoid-mediated up-regulation of ENaC provides new mechanistic insight of the beneficial effect of proanthocyanidins preventing the cardiac alterations induced by aldosterone excess.


Subject(s)
Dietary Supplements , Endosomal Sorting Complexes Required for Transport/antagonists & inhibitors , Epithelial Sodium Channels/metabolism , Heart Ventricles/metabolism , Immediate-Early Proteins/antagonists & inhibitors , Proanthocyanidins/therapeutic use , Protein Serine-Threonine Kinases/antagonists & inhibitors , Ubiquitin-Protein Ligases/antagonists & inhibitors , Ventricular Dysfunction, Left/prevention & control , Animals , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Antihypertensive Agents/therapeutic use , Antioxidants/therapeutic use , Biomarkers/metabolism , Cardiomegaly/etiology , Cardiomegaly/prevention & control , Cardiotonic Agents/therapeutic use , Endosomal Sorting Complexes Required for Transport/agonists , Endosomal Sorting Complexes Required for Transport/metabolism , Epithelial Sodium Channel Agonists/antagonists & inhibitors , Epithelial Sodium Channel Agonists/metabolism , Epithelial Sodium Channel Blockers/therapeutic use , Epithelial Sodium Channels/chemistry , Fibrosis , Heart Ventricles/immunology , Heart Ventricles/pathology , Heart Ventricles/physiopathology , Hypertension/etiology , Hypertension/prevention & control , Immediate-Early Proteins/agonists , Immediate-Early Proteins/metabolism , Male , Mineralocorticoid Receptor Antagonists/therapeutic use , Nedd4 Ubiquitin Protein Ligases , Oxidative Stress , Protein Serine-Threonine Kinases/metabolism , Rats, Wistar , Ubiquitin-Protein Ligases/metabolism , Ventricular Dysfunction, Left/metabolism , Ventricular Dysfunction, Left/pathology , Ventricular Dysfunction, Left/physiopathology
5.
PLoS One ; 11(1): e0145946, 2016.
Article in English | MEDLINE | ID: mdl-26730742

ABSTRACT

We aimed to evaluate macrophages heterogeneity and structural, functional and inflammatory alterations in rat kidney by aldosterone + salt administration. The effects of treatment with spironolactone on above parameters were also analyzed. Male Wistar rats received aldosterone (1 mgkg-1d-1) + 1% NaCl for 3 weeks. Half of the animals were treated with spironolactone (200 mg kg-1d-1). Systolic and diastolic blood pressures were elevated (p<0.05) in aldosterone + salt-treated rats. Relative kidney weight, collagen content, fibronectin, macrophage infiltrate, CTGF, Col I, MMP2, TNF-α, CD68, Arg2, and SGK-1 were increased (p<0.05) in aldosterone + salt-treated rats, being reduced by spironolactone (p<0.05). Increased iNOS and IFN-γ mRNA gene expression (M1 macrophage markers) was observed in aldosterone + salt rats, whereas no significant differences were observed in IL-10 and gene ArgI mRNA expression or ED2 protein content (M2 macrophage markers). All the observed changes were blocked with spironolactone treatment. Macrophage depletion with liposomal clodronate reduced macrophage influx and inflammatory M1 markers (INF-γ or iNOS), whereas interstitial fibrosis was only partially reduced after this intervention, in aldosterone plus salt-treated rats. In conclusion, aldosterone + salt administration mediates inflammatory M1 macrophage phenotype and increased fibrosis throughout mineralocorticoid receptors activation.


Subject(s)
Aldosterone/immunology , Inflammation/pathology , Kidney Diseases/pathology , Kidney/pathology , Macrophages/pathology , Receptors, Mineralocorticoid/immunology , Sodium Chloride/immunology , Aldosterone/administration & dosage , Animals , Fibrosis , Inflammation/drug therapy , Inflammation/immunology , Kidney/drug effects , Kidney/immunology , Kidney Diseases/drug therapy , Kidney Diseases/immunology , Macrophages/immunology , Male , Mineralocorticoid Receptor Antagonists/pharmacology , Rats , Rats, Wistar , Sodium Chloride/administration & dosage , Spironolactone/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...